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The fungus Penicillium brasilianum LaBioMMi 136 was isolated as an endophyte from Melia 
azedarach and has shown to be a prominent producer of great diversity of secondary metabolites, 
although it does not express some biosynthetic routes to other natural compounds found in 
Penicillium genera. The present study aimed at the diversification of P. brasilianum secondary 
metabolism by varying the chemical composition used for its growth. Medium composition 
supplemented with CuSO4 and MnSO4 locked verruculogen biosynthesis and addressed proline to 
the production of a series of cyclodepsipeptides identified as JBIR 113, JBIR 114 and JBIR 115, 
never described for this species so far. The induced cyclodepsipeptide JBIR 113 was isolated by 
the use of combined chromatographic procedures and identified by spectroscopic methods. The 
unique structure with three neighboring cyclic amino acids proline and twice pipecolinic acid is rare 
as natural products and has been described for the first time in terrestrial organism. Verruculogen 
and JBIR 113 exhibited weak antiparasitary activity against Leishmania amazonensis.
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Introduction
Microbial natural products continue to represent an 
important source and inspiration for human therapeutics,1 
providing novel molecular scaffolds and biological 
activities. In the pos genomic era, information concerning 
the biosynthesis of secondary metabolite has been gained 
together with the observation that the number of genes 
encoding biosynthetic enzymes in fungi outnumbers 
the known secondary metabolites synthesized by 
these microorganisms, indicating that only a subset of 
biosynthetic pathway genes is expressed under standard 
laboratory culture conditions.2 Efforts of trying to unlock 
these cryptic secondary metabolites have been made 
worldwide and in many cases successfully accessed using 
molecular and cultivation-based approaches.3 One top-
down methodology is the one strain-many compounds 
(OSMAC) approach in which by systematically modifying 
the fermentation parameters, some of these unknown 
compounds were able to be induced leading to the discovery 
of new fungal natural products.3,4
Penicillium brasilianum LaBioMMi 136, isolated 
as endophyte from the root bark of Melia azedarach, 
has been demonstrated to be an important producer of 
bioactive secondary metabolites, mainly brasiliamides,5 
austin-related insecticidal meroterpenes,6-8 verruculogen-
like tremorgenic alkaloids9 and spirohexalines, which are 
new inhibitors of bacterial undecaprenyl pyrophosphate 
synthase.10 In our continuous studies concerning the 
chemistry and biochemistry of this microorganism, no 
cyclodepsipeptides have been described for this Penicillium 
species so far.
In this study, we aim to unlock cryptic secondary 
metabolites in P. brasilianum LaBioMMi 136 based on the 
OSMAC approach. The modification of culture medium 
composition led to the induction of a secondary metabolite 
identified as the cyclodepsipeptide JBIR 113 1 described for 
the first time in this species which was co-produced to JBIR 
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114 and JBIR 115 identified by liquid chromatography 
tandem mass spectrometry (LC-MS/MS) fragmentation 
pattern. Details of the isolation, structural elucidation, and 
biological assays of JBIR 113 are presented herein.
Experimental
Microorganism
P. brasilianum LaBioMMi 136 used in the present 
work is deposited at the Laboratório de Bioquímica 
Micromolecular de Microorganismos (LaBioMMi) of the 
Departamento de Química, Universidade Federal de São 
Carlos, São Carlos, Brazil.
General experimental procedures
1H NMR, 13C NMR and 2D experiments: gradient-
selected heteronuclear single quantum coherence (gHSQC 
(1H/1H)) and gradient-selected heteronuclear multiple bond 
coherence (gHMBC (1H/13C)), were recorded in CHCl3-d 
(Aldrich) on Bruker Avance III spectrometer operating at 
600 MHz and TMS was used as internal standard. Mass 
spectra (electrospray ionization) were measured in a 
Waters QuattroLC spectrometer. High performance liquid 
chromatography (HPLC) separations were performed on 
a reversed-phase analytical Luna C18 (4.6 × 250 mm, 
5 µm) using a Waters HPLC equipped with a photodiode 
array (PDA). High resolution mass spectrometry (HRMS) 
analyses were obtained on a Thermo Scientific LTQ 
Orbitrap Velos Thermo with an electrospray ionization 
(ESI) ion source. Preparative reversed-phase HPLC 
purifications were performed on a Luna C18 preparative 
column (21.2 × 250 mm, 10 µm) in a Shimadzu SIL-20AP 
VP equipped with a Communication BUS Module 
CMB-20A, LC20AP gradient pumps, SPD-20AV UV 
detector, DGU-20A degasser and LC SOLUTION software. 
Matrix-assisted laser desorption ionization time-of-flight 
(MALDI-TOF) analysis was performed on AutoFlex Speed 
(Bruker Daltonics) controlled by FlexControl 3.3 software.
Fermentation and purification of compound 1
The fungus P. brasilianum was submitted to two 
different cultivation conditions and evaluated concerning 
metabolite production. In the first condition, the fungus 
was grown statically at room temperature in 250 mL 
Erlenmeyer flasks containing 50 mL of Czapeck liquid 
medium composed of glucose (26.7 g L-1), NaNO3 
(3.0 g L-1), K2HPO4 (1.0 g L-1), MgSO4·7H2O (0.5 g L-1), 
KCl (0.5 g L-1), FeSO4·7H2O (0.01 g L-1). The second 
condition evaluated was based on the supplementation 
of the described Czapeck medium with CaCl2, CuSO4, 
glycerol, KCl, MnSO4 in a final concentration of 0.5 g L-1. 
After 15 days fermentation, the mycelium was separated 
by filtration and metabolite extraction was done twice with 
30 mL of ethyl acetate. The mycelium was further extracted 
with ethanol (150 mL) to yield an ethanolic crude extract. 
The combined organic phases (ethyl acetate) obtained were 
dried with Na2SO4, and the solvent was removed under 
reduced pressure producing a yellowish residue, which 
was subjected to low-pressure silica gel CC eluted with a 
hexane to methanol gradient (hexane 100%, hexane:ethyl 
acetate 90:10, hexane:ethyl acetate 50:50, hexane:ethyl 
acetate:methanol 45:45:10, methanol 100%). The fraction 
eluted with hexane:ethyl acetate:methanol 45:45:10 was 
reiteratively chromatographed in preparative reversed-phase 
high performance liquid chromatography (RP-HPLC) using 
the following gradient: 0-15 min, 30% MeOH; 15-30 min, 
70% MeOH; 30-40 min, 90% MeOH; 40-50 min, 100% 
MeOH; and the compound 1 at 27.5 minutes was obtained 
pure (1.5 mg) for further characterization. The mobile phase 
flow rate was 0.7 mL min-1.
Parasites and cells 
Leishmania amazonensis promastigote forms 
(MHOM/BR/Josefa) were maintained at 25 °C in Warren’s 
medium (brain heart infusion plus haemin and folic acid) 
pH 7.0, supplemented with 10% fetal bovine serum (FBS, 
Gibco Invitrogen, Grand Island, NY, USA). Epimastigote 
forms of Trypanossoma cruzi (Y strain) were maintained at 
28 ºC in liver infusion tryptose medium (LIT) supplemented 
with 10% inactivated FBS and trypomastigote forms were 
obtained from the supernatant of a monolayer of infected 
LLCMK2 cells (epithelial cells from the kidney of the 
monkey Macaca mulatta) in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% FBS at 37 °C 
in a humidified 5% CO2 atmosphere. J774A1 murine 
macrophages were maintained in tissue flasks with RPMI 
1640 medium (Gibco Invitrogen Corporation, New York, 
USA) pH 7.6, with sodium bicarbonate and L-glutamine 
added, and supplemented with 10% FBS at 37 °C in a 5% 
CO2-air mixture.
Antiproliferative assay 
The effect of the cyclodepsipeptide JBIR 113 was 
evaluated in promastigotes of L. amazonensis and 
epimastigotes of T. cruzi. The inoculum (1 × 106 cells mL-1) 
was introduced into 24-well plate containing the compounds 
dissolved in dimethyl sulfoxide (DMSO) and Warren’s 
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medium or LIT in several concentrations (1.0-100.0 µM). 
The final concentration of DMSO did not exceed 1%. Cell 
growth was determined by counting the parasites with a 
Neubauer hemocytometer after incubation for 72 h at 25 ºC 
for L. amazonensis or for 96 h at 28 ºC for T. cruzi. The 
results were expressed as percentage of inhibition in relation 
to the control cultured. The 50% inhibitory concentration 
(IC50) was determined by logarithm regression analysis of 
the data obtained.
Viability of trypomastigote forms of T. cruzi
The tissue-culture-derived trypomastigote forms 
(1 × 107 cells mL-1) were resuspended in DMEM and 
added in duplicate to 96-well microplates in presence of 
different concentrations of the compounds (1.0-100.0 µM). 
Parasites were incubated for 24 h at 37 °C in a 5% CO2 
atmosphere. The results were obtained by observing 
motility, allowing the determination of the viability of the 
parasites, using the Pizzi-Brener method.11 The EC50 value 
(i.e., the concentration that lyses 50% of the parasites) was 
then calculated.
Antimicrobial assays
Antibacterial activity was determined essentially as 
described elsewhere12 following the microbroth dilution 
assay as recommended by Clinical and Laboratory 
Standards Institute (2006) (former NCCLS). Antimicrobial 
activity was evaluated against Staphylococcus aureus 
(ATCC 25923), Escherichia coli (ATCC 25922) and 
Pseudomonas aeruginona (ATCC 27853) which had the 
identity confirmed by MALDI-TOF analysis. The assays 
were performed on 96-well plates, in triplicate in the 
concentrations of 100, 50, 25, 12.5, 6.25 and 3.121 µg mL-1 
dissolved in 5% DMSO. The tested bacteria were incubated 
in the Mueller Hinton (MH) broth for 18 h at 37 °C, and 
the bacteria concentration was diluted to approximately 
2.5 × 106 CFU with MH broth. In each well were added 
MH broth (75 µL), test compound (5 µL) and test bacteria 
(20 µL) in order to obtain around 5 × 105 UFC mL-1. The 
plates were incubated at 37 °C overnight. Bioactivity was 
recorded by the use of resazurin dye as blue coloration in 
the wells. Tetracycline was used as a positive control and 
pure DMSO was the negative control.
Results and Discussion
One strain-many compounds (OSMAC) approach 
is an useful method to gain access to cryptic secondary 
metabolites in one single strain by manipulating cultivation 
conditions.4 There are extensive examples in which 
OSMAC approach has been successfully applied to produce 
new secondary metabolites from single fungal strains.4 
Culture medium composition is one of the key factors that 
impact on metabolite production of a microorganism.4,13 
In this sense, the supplementation of different substances 
in the growth media was evaluated concerning metabolite 
production by the fungus P. brasilianum LaBioMMi 136, 
with the aim to induce new fungal metabolites coded on 
its genome but not expressed under standard Czapeck 
cultivation conditions.
P. brasilianum has been demonstrated to be an important 
source for natural products. Among these metabolites, we 
previously described the production and characterization of 
the tremorgenic mycotoxins verruculogen 2, verruculogen 
TR-2 and a C-11 epimer of verruculogen TR-2.9 Following 
the OSMAC approach, our strain P. brasilianum LaBioMMi 
136 has been submitted to different cultivation conditions 
and the addition of CaCl2, CuSO4, glycerol, KCl, MnSO4 
was evaluated concerning the metabolic profile. The 
substances CaCl2, glycerol and KCl showed no impact 
on the metabolism of P. brasilianum, resulting in the 
same chromatographic pattern when analyzed by LC-MS 
compared to standard condition of growth (data not 
shown). On the other hand, the analysis of the ethanolic 
fraction obtained by mycelium extraction, indicated that 
the addition of CuSO4 led to completely inhibition of 
verruculogen 2 biosynthesis by the fungus using the new 
cultivation conditions as indicated in the chromatogram 
shown in Figure 1. MnSO4 also had an important influence 
on P. brasilianum secondary metabolism and the decrease 
on verruculogen 2 production was observed.
In addition to the lack of the fungus’s ability to 
synthesize verruculogen 2 in the medium supplemented 
with CuSO4 and MnSO4, P. brasilianum was able to 
induce a new compound under these conditions which 
was detected by HPLC-MS in the ethyl acetate fraction 
and was not observed under standard Czapeck cultivation 
conditions as indicated in the control experiment shown in 
Figure 2. The induced compound was isolated by the use 
of combined chromatographic procedures and identified by 
physical methods, mainly 1D and 2D NMR experiments 
and HRMS analysis.
Compound 1 was obtained as a colorless amorphous solid 
and it was assigned the molecular formula C31H42N5O7 via 
HRESIMS data (m/z for 596.3051 [M + H]+), establishing 
an index of hydrogen deficiency (IHD) of 13. 1H NMR 
(Table 1) revealed the presence of five α protons at dH 4.70, 
4.47, 4.57, 4.26 and 4.92 for H-2, H-8, H-14, H-19 and H-22, 
respectively. Moreover, two NH protons at dH 7.17 and 7.20 
were observed. 13C NMR pointed six carbonyl carbons at 
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Figure 1. (A) Metabolic profile of P. brasilianum LaBioMMi 136 cultivated in Czapeck standard medium; (B) UV spectrum of 2 produced by the fungus 
in standard conditions; (C) metabolic profile of P. brasilianum LaBioMMi 136 under the influence of CuSO4 added in the medium, indicating verruculogen 
2 biosynthesis abolished; (D) chemical structure of 2 and the UV spectrum of 2 standard, respectively.
Figure 2. (A) Metabolic profile of P. brasilianum LaBioMMi 136 cultivated in standard cultivation conditions and under the influence of CuSO4, respectively; 
(B) selected ion chromatogram of m/z 596 of control and CuSO4 culture, respectively; (C) chemical structure of the cyclodepsipeptide JBIR 113 1 induced.
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dC 174.3, 169.3, 173.4, 172.4, 169.0 and 167.6 related to 
C-1, C-7, C-13, C-18, C-21 and C-25, respectively. These 
spectral features collectively suggested the peptide nature 
of the molecule. Correlation spectrometry (COSY) and 
HMBC were the key in the establishment of spin systems 
(Figure 3), leading to the identification of a threonine (Thr) 
moiety (from NH at d 7.20 to H-22 and H-23 and from H-23 
to H-24), an alanine (Ala) moiety (from NH at d 7.17 to 
H-19 and from H-19 to H-20), a proline (Pro) moiety (from 
α protons at d 4.57 to H-15a/b and from methylene proton 
at d 1.70 to H-17a), and two pipecolic acid (Pip) residues 
(from α protons at d 4.47 and 4.70 to C-3, C-4 and C5, and 
C-9, C10, C-12, respectively).
Furthermore, the 1H NMR and COSY spectra revealed 
the presence of aromatic hydrogens H-27/31, H-28/30 
and H-29. COSY correlations from H-27/31 (7.84, d, 7.4) 
to H-28/30 (7.47, t, 7.4) and H-28/30 to H-29 (7.53, t, 
7.4) and HMBC correlations from H-28 ↔ C-26 (134.1) 
and from H-27/31 ↔ C-25 (167.7), indicating a benzoyl 
group. Correlations of α and NH protons to each carbonyl 
carbons supported to establish the connectivities of the 
amino acids and the benzoyl unit. HMBC correlations from 
H-2 at dH 4.47, α methine hydrogen of Pip 1, to a carbonyl 
carbon of Pip 2 at dC 174.3, from α methine hydrogen of 
Pip 2 at dH 4.70 to carbonyl carbon of Pro at dC 173.4, from 
β-methylene hydrogen H-15a at dH 2.09 to carbonyl carbon 
of Pro and to carbonyl carbon of Ala at dC 172.4, from an 
α-methine hydrogen Ala H-19 at dH 4.25 to a carbonyl 
carbon of Thr C-21 at dC 168.0, from an amide hydrogen 
of Thr -NH at dH 7.20 to a carbonyl carbon of Bz C-25 at 
dC 167.6. Furthermore, the correlation from the oxymethine 
hydrogen of Thr H-23 at dH 5.29 to a carbonyl carbon of 
Pip 1 C-1 at dC 169.3 represents the connection between 
them and shows an ester bond, indicating the chemical 
structure of a depsipeptide.
Fragmentation studies were performed in order to 
establish the correct connectivity between amino acids 
in the cyclodepsipeptide JBIR 113. The MS data were 
acquired in positive ion mode to produce the molecular 
ion [M + H]+ at m/z 596 by protonation of the nitrogen 
atom in the peptide bond involved in the correspondent 
ring opening, according to our theoretical fragmentation 
proposal. The product ion spectra of compound 1 showed 
m/z 485, 467, 374, 356, 280, 209, 140, 112 and 70 as the 
most abundant product ions, being the result of the two 
most important ring openings 1 and 2 as assigned in the 
structure of compound 1 (Figure 4).
Table 1. NMR data of compound 1 (600 MHz, CDCl3)
Unit Position dH, m (J in Hz) dc
Pip 1 1 − 169.0
2 4.47 53.5
3a 1.87, ovla 27.3
3b 1.93, ovla
4 1.65, ovla 18.5
5a 1.40, ovla 23.9
5b 1.82, ovla
6 3.32, ovla 39.1
Pip 2 7 − 174.3
8 4.70, dl (4.1) 50.9
9a 1.84, ovla 26.2
9b 1.99, ovla
10 1.75-1.65, m 18.8
11a 1.70, ovla 24.0
11b 1.83, ovla
12a 3.70, ovla 43.5
12b −
Pro 13 − 173.4
14 4.57, ovla 59.1
15a 2.09, ovla 30.0
15b 2.41, ovla
16a 1.84, ovla 24.0
16b 1.70, ovla
17a 3.67, ovla 47.4
17b 3.58, ovla
Ala 18 − 172.4
19 4.26-4.24, m 47.45
20 1.27, d (3.6) 19.7
NH 7.21-7.17, m −
Thr 21 − 168.0
22 4.92, d (8.2) 55.7
23 5.29, q (6.2) 73.3
24 1.34, d (5.8) 17.1
NH 7.21-7.17, m −
Bz 25 − 167.7
26 − 134.1
27 7.84, d (7.4) 127.3
28 7.47, t (7.4) 128.5
29 7.53, t (7.4) 131.7
aOverlapped with other signals.
Figure 3. Key correlations COSY (bold lines) and HMBC (arrows) of 
compound 1.
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Figure 4. (A) Product ion of [M + H]+ at m/z 596 and possibilities of ring opening; (B) fragmentation proposal for compound 1.
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The proposal is based on the ring opening mechanisms 
followed by a sequence of 1,3 H shifts as indicated in the 
proposal. The first H shift proceeds with CO and C5H7N 
losses leading to the ions m/z 485 (ring opening 1) and 
m/z 485 (ring opening 2) which further go through a 
new 1,3 H shift in two different positions as indicated in 
Figure 4, leading to m/z 280 (ring opening 1) and m/z 374 
and 356 (ring opening 2). Finally one last 1,3 H shift is 
responsible for the formation of the further ions. Based 
on the product ions and fragmentation proposal, we were 
able to assign the correct positions of the amino acids in 
the structure of compound 1. The cyclodepsipeptides JBIR 
114 and JBIR 115 (Figure 5) were co-produced to JBIR 
113 by the fungus P. brasilianum as indicated by LC-MS/
MS analyses with similar peptide fragmentation pattern 
(Supplementary Information, Figure S7).
MS/MS data of JBIR 114 indicated characteristic 
loss of one Pip (m/z 493) and two Pro (m/z 396 and 299), 
respectively. On the other hand, MS/MS pattern of JBIR 
115 indicated loss of a Pro (m/z 489) which allowed 
distinguishing both isomers due to the loss of a proline 
unit (Supplementary Information, Figure S7). A few other 
cyclodepsipeptides were induced by the culture conditions 
and are currently under investigation in our laboratory.
Compound 1 was identified as the cyclodepsipeptide 
JBIR 113 already described by Kawahara et al.,14 which 
was produced by a marine sponge-derived Penicillium sp. 
fS36 isolated in Japan and was co-produced to other 
two cyclodepsipeptides JBIR 114 and JBIR 115 that 
differentiates in the composition and sequence of the 
amino-acid residues13 (Figure 5). This cyclodepsipeptides 
are structurally related to petrosifungins which are novel 
cyclodepsipeptides from Penicillium brevicompactum 
derived from a specimen of the Mediterranean sponge 
Petrosia ficiformis.15 Petrosifungins A and B are 
cyclodepsipeptides containing two neighboring units of 
the nonproteinogenic amino acid L-pipecolinic acid as 
in JBIR 113 produced by P. brasilianum. A noteworthy 
structural feature of the petrosifungins and JBIR 113 
structures is the array of the three neighboring cyclic amino 
acids proline and twice pipecolinic acid, which are the 
only examples of this sequence in natural cyclopeptides.15 
Although other peptides containing pipecolic acid have 
been reported, including neamphamide A16 from a marine 
sponge and microsporins A and B17 from a marine sponge-
derived fungus, these peptides are very rare in natural 
products and are all of marine origin and it is the first time 
described by a terrestrial microorganism.
Compound 1 isolated from P. brasilianum was 
submitted to biological assays and evaluated against 
promastigote forms of L. amazonensis and epimastigote 
and trypomastigote forms of T. cruzi. The compound 1 
was found inactive in the bioassays exhibiting an IC50 
value (inhibitory concentration for 50% of the parasites) 
of 63.2 ± 2.5 µM. Compound 1 was found to be inactive 
concerning antimicrobial activity against Pseudomonas 
aeruginosa, Staphylococcus aureus or Escherichia coli. 
Although the negative result was given, further studies still 
need to explore their potential bioactivity.
It is well-established that fumitremorgen-verruculogen 
metabolites are biochemically derived from tryptophan, 
proline and one or more mevalonic acid moieties18 
confirmed by isotopically labeling studies and recent 
molecular approaches. From our understanding, it seems 
that the fungus P. brasilianum has the ability to redirect the 
amino acid proline that was once used for verruculogen 
production to biosynthesize the cyclodepsipeptides JBIR 
113, JBIR 114 and JBIR 115 which contains a proline in 
its chemical structure and is not produced under standard 
cultivation conditions.
P. brasilianum LaBioMMi 136 recently had its genome 
sequenced (data not published) and the related information 
was submitted to prediction tools that find gene clusters 
and pathways in fungal genomes. AntiSmash19 analysis 
Figure 5. Chemical structures of the cyclodepsipeptides JBIR 113, JBIR 114 and JBIR 115 produced by P. brasilianum.
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indicated that P. brasilianum has the potential to produce a 
diverse array of natural products. According to antiSmash 
analysis, there are 42 putative biosynthetic gene clusters in 
P. brasilianum LaBioMMi 136 containing, among others, 
22 backbone genes, of which 12 are nonribosomal peptide 
synthetases (NRPSs); indicating the great genetic and 
enzymatic machinery potential for the production of peptide 
related metabolites. Further studies will be performed in 
order to understand JBIR 113 biosynthetic cluster.
Conclusions
The future of microbial natural product drug discovery 
and development remains bright and OSMAC approach is 
a good strategy to gain access to new natural products from 
a single fungal strain. The present studies have showed 
that microorganisms are sensitive to culture media for 
production of secondary metabolites, and that changing the 
culture medium could lead to changes in metabolite profiles. 
By the addition of different salts in the culture medium, 
P. brasilianum locked the production of verruculogen and 
at the same time redirect the amino acid proline to produce 
a series of cyclodepsipeptides never described for this 
species before and characteristic of marine fungal species, 
describing the ability of a terrestrial organism to produce 
cyclodepsipeptides with three neighboring cyclic amino 
acids proline and twice pipecolinic acid.
Supplementary Information
Supplementary data (NMR, MS, MS/MS spectra) are 
available free of charge at http://jbcs.sbq.org.br as PDF file.
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